Skip to main content

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

SGMT holding history

Sagimet Biosciences Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SGMT overviewAll 13F holders of SGMTFull Q2 2026 holdings

Shares (Q2 2026)
2,497,864
Value
$19.3M
% of portfolio
0.9%
Quarters held
4
Since Q3 2025
Holdings of SGMT by Affinity Asset Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,497,864$19.3M0.9%+1,629,844+187.8%AddedHolders
Q1 2026868,020$4.54M0.3%−280,225−24.4%ReducedHolders
Q4 20251,148,245$6.80M0.5%+798,245+228.1%AddedHolders
Q3 2025350,000$2.40M0.2%+350,000NewHolders